Atnaujinkite slapukų nuostatas

El. knyga: No Time to Lose: Getting More from HIV Prevention

  • Formatas: 253 pages
  • Išleidimo metai: 02-Feb-2001
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309501828
Kitos knygos pagal šią temą:
  • Formatas: 253 pages
  • Išleidimo metai: 02-Feb-2001
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309501828
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The United States has spent two productive decades implementing a variety of prevention programs. While these efforts have slowed the rate of infection, challenges remain. The United States must refocus its efforts to contain the spread of HIV and AIDS in a way that would prevent as many new HIV infections as possible. No Time to Lose presents the Institute of Medicine's framework for a national prevention strategy.

Table of Contents



Front Matter Executive Summary Introduction: Rethinking HIV Prevention Tracking the Epidemic Allocating Resources Using the Clinical Setting Translating Research into Action Searching for New Tools Overcoming Social Barriers Appendix A: The Changing Epidemic Appendix B: The Prevention Portfolio: Interventions to Prevent HIV Infection Appendix C: Federal Spending on HIV / AIDS Appendix D: Description and Mathematical Statement of the HIV Prevention Resource Allocation Model Appendix E: Data Gathering Activities Appendix F: Agendas for Public Committee Meetings Appendix G: Biographies Index
Executive Summary 1(10)
Introduction: Rethinking HIV Prevention
11(3)
Tracking the Epidemic
14(12)
National AIDS Surveillance System
15(1)
Rationale for a National System of HIV Surveillance
16(1)
HIV Case Reporting
16(3)
Population-Based HIV Incidence Estimation
19(7)
Allocating Resources
26(24)
Current Allocation of Federal HIV Prevention Funds
28(4)
Assessing the Cost-Effectiveness of HIV Prevention Interventions
32(3)
Protecting the Blood Supply
33(1)
Preventing Perinatal Transmission of HIV
34(1)
Implementing Needle Exchange Programs
34(1)
Using Epidemic Impact as a Measure of Success
35(2)
A Strategic Vision for HIV Prevention Investments
37(1)
Resource Allocation for HIV Prevention
38(8)
Allocating Resources at the Community Level
39(1)
Allocating Resources at the National Level
39(7)
Support for State and Local Resource Allocation
46(4)
Using the Clinical Setting
50(18)
Clinical Care-Based Prevention
51(4)
Programs That Provide Clinical Care to HIV-infected Persons
55(3)
Financing of HIV Care
56(2)
Changes Needed to Encourage HIV Prevention: Medicaid and Ryan White Care Act Programs
58(5)
Financing Options for Medicaid Coverage
58(3)
Encouraging HIV Prevention in CARE Act Programs
61(2)
DHHS-wide Policies to Encourage Integration of Prevention into Clinical Care
63(5)
Translating Research into Action
68(12)
Current Efforts in Prevention Technology Transfer
68(4)
Barriers to Effective Technology Transfer at the Community Level
72(2)
Opportunities for Improving Prevention Technology Transfer
74(6)
Searching for New Tools
80(17)
Promising New Tools
80(9)
Rapid Testing Methods for Detecting HIV Antibodies
80(3)
Alternative Barrier Methods
83(3)
Antiretroviral Therapies
86(1)
Vaccines
87(2)
Promising New Collaborations
89(8)
Overcoming Social Barriers
97(116)
Social Barriers
98(8)
Poverty, Racism, and Gender Inequality
98(2)
The Sexual ``Code of Silence,''
100(1)
Stigma of HIV/AIDS
101(2)
Misperceptions
103(1)
Lack of Leadership
104(2)
Unrealized Opportunities
106(33)
Access to Drug Treatment and Sterile Injection Equipment
106(10)
Comprehensive Sex Education and Condom Availability in Schools
116(4)
HIV Prevention in Correctional Settings
120(19)
APPENDIXES
A The Changing Epidemic
139(13)
B The Prevention Portfolio: Interventions to Prevent HIV Infection
152(10)
C Federal Spending on HIV/AIDS
162(11)
D Description and Mathematical Statement of the HIV Prevention Resource Allocation Model
173(7)
E Data Gathering Activities
180(14)
F Agendas for Public Committee Meetings
194(6)
G Biographies
200(13)
Index 213


Committee on HIV Prevention Strategies in the United States, Division of Health Promotion and Disease Prevention, Monica S. Ruiz, Alicia R. Gable, Edward H. Kaplan, Michael A. Stoto, Harvey V. Fineberg, and James Trussell, Editors